Description
+ Description
Ace-031, also known as ACVR2B, is a soluble form of activin type IIB receptor, which is an inhibitor of myostatin and other naturally occurring proteins that limit muscle growth. This compound was genetically developed to bind to myostatin before it can attach to its receptor and halt muscle growth. The two Biopharma companies that worked on this compound are Acceleron and Shire.
GHRP-2 is a sterile, non-pyrogenic, white lyophilized powder intended for subcutaneous or intramuscular injection, after reconstitution with sterile Water for Injection (0,3% m-Cresol).
+ Adverse reaction
ACE-031 could have the following side effects:
- Water Retention
- Bleeding from the nose
- Increased Hunger
- Headache
- Reactions at injection site
+ Dosage
Recommended dosage of ACE-031: 500 – 1.000 mcg twice a week
Reviews
There are no reviews yet.